Cointime

Congenica

company

About

Congenica is a biotechnology company that provides a diagnostic decision support platform.

  • 51 - 100

Highlights

Total Funding Amount
£24.70M $50M
Funding Rounds
6
Investors
3

Details

Last Funding Type
Series B
Last Funding Money Raised
£8M
Industries
Bioinformatics,Biotechnology,Genetics,Health Care,Medical
Founded date
Jan 1, 2012
Number Of Employee
51 - 100
Operating Status
Active

Congenica is a biotechnology company that provides a diagnostic decision support platform. They have translated this research into the gold standard clinical genomic analytics platform, Sapientia, providing integration of human DNA sequences with deep clinical phenotyping, enabling clinicians to provide an actionable interpretation of genetic disease for patients.

It was founded in 2013 and headquartered in Cambridge, Cambridgeshire.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
6
£24.70M $50M
Congenica has raised a total of £24.70M $50M in funding over 2 rounds. Their latest funding was raised on Nov 9, 2020 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 9, 2020 Series C $50M 1 — — Detail
Apr 30, 2019 Series B £13.50M 1 — — Detail
Apr 27, 2017 Series B — 1 — — Detail
Feb 27, 2017 Series B £8M 1 — — Detail
Apr 14, 2015 Series A £2.20M 1 — — Detail
Show More

Investors

Number of Lead Investors
Number of Investors
1
3
Congenica is funded by 3 investors. Cambridge Innovation Capital and Digital China Health Technologies Corporation (DCHealth) are the most recent investors.
Investor Name Lead Investor Funding Round
Cambridge Innovation Capital — Series C
Digital China Health Technologies Corporation (DCHealth) — Series B
Healthlink Capital — Series B
Cointime
เนื้อหา
บริษัท